Amy C. Moore, PhD
@acmoorephd.bsky.social
Internationally-recognized KOL and patient advocate. Director, Patient Engagement & Advocacy at Summit Therapeutics.
Views = my own
Views = my own
Pinned
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024 - OncoDaily
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024 / 100 Influential Women in Oncology, 100 Questions and Answers about
oncodaily.com
Humbled to be included on @oncodaily.bsky.social's list of 100 Influential Women in Oncology for 2024. Check out the full list of the trailblazers who are changing the face of cancer research, patient care and advocacy around the globe oncodaily.com/positive/100...
Kiss them. They’re Irish. ☘️ 🌈
March 16, 2025 at 11:52 PM
Kiss them. They’re Irish. ☘️ 🌈
Reposted by Amy C. Moore, PhD
Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy
@acmoorephd.bsky.social
oncodaily.com/blog/255749
#Cancer #Medicine #PatientAdvocacy #Health #HealthCare #Oncology #OncoDaily
@acmoorephd.bsky.social
oncodaily.com/blog/255749
#Cancer #Medicine #PatientAdvocacy #Health #HealthCare #Oncology #OncoDaily
Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy - OncoDaily
Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy / Amy C. Moore, cancer, ivonescimab, Lung cancer, OncoDaily,
oncodaily.com
March 15, 2025 at 9:03 PM
Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy
@acmoorephd.bsky.social
oncodaily.com/blog/255749
#Cancer #Medicine #PatientAdvocacy #Health #HealthCare #Oncology #OncoDaily
@acmoorephd.bsky.social
oncodaily.com/blog/255749
#Cancer #Medicine #PatientAdvocacy #Health #HealthCare #Oncology #OncoDaily
Digging around in the basement and found this old award from AACR broken. But I glued it back together. Because science may be down right now, but it’s not out. We will put the pieces back together.
February 23, 2025 at 1:16 AM
Digging around in the basement and found this old award from AACR broken. But I glued it back together. Because science may be down right now, but it’s not out. We will put the pieces back together.
Reposted by Amy C. Moore, PhD
Here is the pre-RFK vaccination schedule for your kids. Please download it before he is confirmed and changes/deletes it.
Give it to your pediatrician and say this is the schedule you want your kids on.
Making this my pinned post.
Give it to your pediatrician and say this is the schedule you want your kids on.
Making this my pinned post.
February 4, 2025 at 9:01 PM
Here is the pre-RFK vaccination schedule for your kids. Please download it before he is confirmed and changes/deletes it.
Give it to your pediatrician and say this is the schedule you want your kids on.
Making this my pinned post.
Give it to your pediatrician and say this is the schedule you want your kids on.
Making this my pinned post.
I am proud to have worked with LUNGevity’s partners to develop these #lungcancer resources for members of the AANHPI community lungevity.org/health-equity #LCSM
February 2, 2025 at 5:12 PM
I am proud to have worked with LUNGevity’s partners to develop these #lungcancer resources for members of the AANHPI community lungevity.org/health-equity #LCSM
Reposted by Amy C. Moore, PhD
As February begins, we embrace a month dedicated to recognizing the extraordinary achievements of Black individuals who have shaped our world. Their stories inspire us to rise, challenge the status quo, and create a future filled with hope and progress.
February 1, 2025 at 6:56 PM
As February begins, we embrace a month dedicated to recognizing the extraordinary achievements of Black individuals who have shaped our world. Their stories inspire us to rise, challenge the status quo, and create a future filled with hope and progress.
Reposted by Amy C. Moore, PhD
I’m an NSF panel reviewer that was scheduled to meet today. Just got notice that all NSF panels were canceled today. I reviewed some innovative proposals in support of students. Devastating if these scholars don’t get to do this work. For the love of science & students I hope this is just a delay.💔
January 27, 2025 at 2:45 PM
I’m an NSF panel reviewer that was scheduled to meet today. Just got notice that all NSF panels were canceled today. I reviewed some innovative proposals in support of students. Devastating if these scholars don’t get to do this work. For the love of science & students I hope this is just a delay.💔
Having landed my first job outside my postdoc through a cold email, I know the power of that communication and how it can open doors www.nature.com/articles/d41...
Four tips for writing the perfect ‘cold e-mail’ in job applications
These strategies can transform your unsolicited applications from forgettable to fabulous.
www.nature.com
January 27, 2025 at 3:45 PM
Having landed my first job outside my postdoc through a cold email, I know the power of that communication and how it can open doors www.nature.com/articles/d41...
As a scientist and an advocate, I am grateful for LUNGevity's commitment to continue to work on behalf of ALL people at risk for and impacted by #lungcancer as well as the researchers working to find new treatments. #LCSM
LUNGevity is unwavering in our commitment to funding high-quality lung cancer research, supporting patients and their families, and advocating for health equity, increased awareness, early detection, and improved treatments for lung cancer.
January 27, 2025 at 3:43 PM
As a scientist and an advocate, I am grateful for LUNGevity's commitment to continue to work on behalf of ALL people at risk for and impacted by #lungcancer as well as the researchers working to find new treatments. #LCSM
The good news is my ping pong game has really improved this week. Burning off some steam!
a cat is sitting on a ping pong table looking at a blue balloon .
ALT: a cat is sitting on a ping pong table looking at a blue balloon .
media.tenor.com
January 25, 2025 at 8:08 PM
The good news is my ping pong game has really improved this week. Burning off some steam!
Reposted by Amy C. Moore, PhD
As a cancer patient community, we are lost for words. Science and research is what keeps us all going.
As Dr @choo.bsky.social said, “There are real people, real lives waiting on the science.”
nature.com/articles/d4158…#LCSMSM
As Dr @choo.bsky.social said, “There are real people, real lives waiting on the science.”
nature.com/articles/d4158…#LCSMSM
January 25, 2025 at 9:58 AM
As a cancer patient community, we are lost for words. Science and research is what keeps us all going.
As Dr @choo.bsky.social said, “There are real people, real lives waiting on the science.”
nature.com/articles/d4158…#LCSMSM
As Dr @choo.bsky.social said, “There are real people, real lives waiting on the science.”
nature.com/articles/d4158…#LCSMSM
A good distraction from a cat-astrophic week for science
January 25, 2025 at 3:54 AM
A good distraction from a cat-astrophic week for science
Efforts to support clinical trial diversity now at risk www.statnews.com/2025/01/23/f...
FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban
Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring diversity in drug trials.
www.statnews.com
January 24, 2025 at 12:40 PM
Efforts to support clinical trial diversity now at risk www.statnews.com/2025/01/23/f...
One of my frustrations with our work to understand the causes of #cancer #cachexia as part of Cancer Grand Challenges Team #CANCAN is the limitation of animal models that don't reflect the realities of the patient population. This development helps. #LCSM #lungcancer
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Concurrent PIK3CA mutant drives cachexia through inflammatory signaling in EGFR mutant lung cancer
PIK3CA mutation is frequently concurrent with known oncogenic drivers such as EGFR mutation in lung cancer, raising an interesting question about its real function. Cachexia is a systemic disease invo...
www.biorxiv.org
January 23, 2025 at 7:52 PM
One of my frustrations with our work to understand the causes of #cancer #cachexia as part of Cancer Grand Challenges Team #CANCAN is the limitation of animal models that don't reflect the realities of the patient population. This development helps. #LCSM #lungcancer
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Reposted by Amy C. Moore, PhD
"Any prolonged pause of the #NIH’s study sections could result in funding delays for scientific labs awaiting approval of their work." #CanSky #MedSky #IDSky
www.statnews.com/2025/01/22/t...
www.statnews.com/2025/01/22/t...
Trump administration’s abrupt cancellation of scientific meetings prompts confusion, concern
A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the
www.statnews.com
January 23, 2025 at 5:30 AM
"Any prolonged pause of the #NIH’s study sections could result in funding delays for scientific labs awaiting approval of their work." #CanSky #MedSky #IDSky
www.statnews.com/2025/01/22/t...
www.statnews.com/2025/01/22/t...
Reposted by Amy C. Moore, PhD
First-Line Amivantamab Plus Lazertinib Wins EU Approval for EGFR+ Advanced NSCLC #lcsm #oncology www.onclive.com/view/first-l...
First-Line Amivantamab Plus Lazertinib Wins EU Approval for EGFR+ Advanced NSCLC
The European Commission approved first-line amivantamab plus lazertinib for EGFR-mutated advanced non–small cell lung cancer.
www.onclive.com
January 21, 2025 at 4:12 PM
First-Line Amivantamab Plus Lazertinib Wins EU Approval for EGFR+ Advanced NSCLC #lcsm #oncology www.onclive.com/view/first-l...
My cat may be slightly spoiled
January 20, 2025 at 2:23 PM
My cat may be slightly spoiled
Reposted by Amy C. Moore, PhD
9.5% MET and 7.9% EGFR detected in pts w lung SqCC with no smoking history.
Important to improve testing in this group. We are finding more of this with reflex testing in early stage disease.
#lcsm
Important to improve testing in this group. We are finding more of this with reflex testing in early stage disease.
#lcsm
Biomarker testing can help identify actionable mutations in patients with SqNSCLC, especially in those without a history of smoking. Testing is not performed consistently in this setting. #LCSM #lungcancer
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking
Next-generation sequencing (NGS) to detect actionable genomic driver alterations (AGAs) is critical to appropriate management of non-small cell lung c…
www.sciencedirect.com
January 19, 2025 at 4:48 PM
9.5% MET and 7.9% EGFR detected in pts w lung SqCC with no smoking history.
Important to improve testing in this group. We are finding more of this with reflex testing in early stage disease.
#lcsm
Important to improve testing in this group. We are finding more of this with reflex testing in early stage disease.
#lcsm
We still have a long way to go to ensure that ALL patients benefit from recent scientific advances in #lungcancer. This study found that overall survival increased by 71% in patients with private insurance compared to only 24% in the uninsured in the US. #LCSM
www.jtocrr.org/article/S266...
www.jtocrr.org/article/S266...
Recent Survival Gains in Stage IV Non-Small Cell Lung Cancer by Sociodemographic Strata
The management of stage IV non-small cell lung cancer (NSCLC) has been transformed
by recent innovations. However, access to medical innovations can be variable across
sociodemographic groups in the U...
www.jtocrr.org
January 19, 2025 at 3:59 PM
We still have a long way to go to ensure that ALL patients benefit from recent scientific advances in #lungcancer. This study found that overall survival increased by 71% in patients with private insurance compared to only 24% in the uninsured in the US. #LCSM
www.jtocrr.org/article/S266...
www.jtocrr.org/article/S266...
Biomarker testing can help identify actionable mutations in patients with SqNSCLC, especially in those without a history of smoking. Testing is not performed consistently in this setting. #LCSM #lungcancer
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking
Next-generation sequencing (NGS) to detect actionable genomic driver alterations (AGAs) is critical to appropriate management of non-small cell lung c…
www.sciencedirect.com
January 19, 2025 at 3:58 PM
Biomarker testing can help identify actionable mutations in patients with SqNSCLC, especially in those without a history of smoking. Testing is not performed consistently in this setting. #LCSM #lungcancer
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by Amy C. Moore, PhD
Excellent review of lung neuroendocrine neoplasms by Dr Sen,
@naglaakarimmd.bsky.social and team! Terrific discussion of molecular landscape, existing therapeutic challenges, and diagnosis & management strategies.
#LCSM #LungNETs #SCLC
@thelancet.bsky.social
www.thelancet.com/journals/lan...
@naglaakarimmd.bsky.social and team! Terrific discussion of molecular landscape, existing therapeutic challenges, and diagnosis & management strategies.
#LCSM #LungNETs #SCLC
@thelancet.bsky.social
www.thelancet.com/journals/lan...
January 7, 2025 at 2:58 AM
Excellent review of lung neuroendocrine neoplasms by Dr Sen,
@naglaakarimmd.bsky.social and team! Terrific discussion of molecular landscape, existing therapeutic challenges, and diagnosis & management strategies.
#LCSM #LungNETs #SCLC
@thelancet.bsky.social
www.thelancet.com/journals/lan...
@naglaakarimmd.bsky.social and team! Terrific discussion of molecular landscape, existing therapeutic challenges, and diagnosis & management strategies.
#LCSM #LungNETs #SCLC
@thelancet.bsky.social
www.thelancet.com/journals/lan...